Concurrent Use of Celebrex and Eliquis

Introduction to Risks

The American Academy of Family Physicians notes that both celecoxib and apixaban can independently increase bleeding risk - celecoxib through its antiplatelet effects and apixaban through its direct anticoagulant mechanism 1, 2
The American Family Physician reports that NSAIDs, including COX-2 inhibitors like celecoxib, can increase the risk of GI bleeding when combined with anticoagulants by 3-6 times 1
Patients with a history of GI bleeding are at particularly high risk when using this combination 1, 2

The American Heart Association recommends considering non-pharmacological pain management approaches first 3, 4
The American Family Physician suggests considering acetaminophen as an alternative to celecoxib when possible 5
If celecoxib is required, the American College of Cardiology recommends determining if it's for short-term or chronic use 4

High-risk patients (contraindicated combination) include those with a history of GI bleeding 1, advanced age (>75 years) 1, 5, renal dysfunction (CrCl <30 mL/min) 6, 2, hepatic impairment 5, and uncontrolled hypertension 7, 5
Moderate risk (use with extreme caution) includes patients aged 65-75 years 1, with stable cardiovascular disease 4, 7, and mild-moderate renal impairment 5

The American Family Physician recommends using the lowest effective dose of celecoxib (100mg daily or 100mg twice daily) 7
The American College of Cardiology suggests considering adding a proton pump inhibitor for GI protection 5
Regular monitoring is necessary for signs of bleeding 1, 2, renal function and blood pressure 7, 5, and patient education on signs of bleeding to report immediately 4

Regular monitoring of complete blood count is recommended by the Journal of the National Comprehensive Cancer Network 2
Monitoring for occult blood in stool is suggested by the American Family Physician 1
Regular blood pressure measurements are recommended by the American Heart Association 7, 5
Renal function tests are necessary, as recommended by the American Family Physician 5
Signs of GI distress or bleeding should be monitored, as recommended by the American Family Physician 1

The American Heart Association warns that NSAIDs, including COX-2 inhibitors like celecoxib, can increase cardiovascular risk and should be used with caution in patients with cardiovascular disease 4, 7
Studies show that combining NSAIDs with anticoagulants increases bleeding risk 3-6 times compared to anticoagulants alone, as reported by the American Family Physician 1
The Journal of the National Comprehensive Cancer Network notes that potential drug interactions affecting apixaban metabolism through CYP3A4 and P-glycoprotein pathways should be considered 2